New hope for Tough-to-Treat breast cancer: multiple drug combos tested
NCT ID NCT03280563
Summary
This study tested several immunotherapy-based drug combinations for people with advanced HR-positive, HER2-negative breast cancer that had worsened despite standard hormone therapy. It involved 144 participants who received different combinations of drugs, including a standard hormone therapy as a comparison. The goal was to see which combinations could best shrink tumors and control the cancer while monitoring side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21231, United States
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, California, 90502, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
National Cancer Center
Gyeonggi-do, 10408, South Korea
-
Northwest Georgia Oncology Centers PC - Marietta
Marietta, Georgia, 30060, United States
-
Providence Cancer Center
Portland, Oregon, 97231, United States
-
Rabin Medical Center-Beilinson Campus
Petah Tikva, 4941492, Israel
-
Rambam Medical Center
Haifa, 3109601, Israel
-
Sarah Cannon Research Institute / Tennessee Oncology
Nashville, Tennessee, 37203, United States
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Shaare Zedek Medical Center
Jerusalem, 9103102, Israel
-
Sheba Medical Center
Ramat Gan, 5262100, Israel
-
Stanford Cancer Institute
Stanford, California, 94305-5456, United States
-
Tel Aviv Sourasky Medical Center
Tel Aviv, 64239, Israel
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
-
UCSF Helen Diller Family CCC
San Francisco, California, 94158, United States
-
UPMC Pinnacle Health System
Harrisburg, Pennsylvania, 17102, United States
-
Univ of Pittsburgh Sch of Med
Pittsburgh, Pennsylvania, 15213, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
-
University of Ulsan College of Medicine - Asan Medical Center
Seoul, 05505, South Korea
-
Wellness Oncology and Hematology - Main Office
West Hills, California, 91307, United States
Conditions
Explore the condition pages connected to this study.